LivaNova Plc (LIVN) - Financial and Strategic SWOT Analysis Review

LivaNova Plc (LIVN) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation products provide vagus nerve stimulation therapy system, an implantable device for people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for the autotransfusion and autologous blood washing, perfusion charting system, among others. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, Greater London, the UK.LivaNova Plc Key Recent Developments

May 23,2024: LivaNova to Present at the Goldman Sachs Healthcare Conference
May 01,2024: LivaNova Reports First-Quarter 2024 Results
Apr 30,2024: LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
Apr 30,2024: LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
LivaNova Plc - Key Facts
LivaNova Plc - Key Employees
LivaNova Plc - Key Employee Biographies
LivaNova Plc - Major Products and Services
LivaNova Plc - History
LivaNova Plc - Company Statement
LivaNova Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
LivaNova Plc - Business Description
Business Segment: Advanced Circulatory Support
Overview
Performance
Business Segment: Cardiopulmonary
Overview
Performance
Business Segment: Neuromodulation
Overview
Performance
Business Segment: Other
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
LivaNova Plc - Corporate Strategy
LivaNova Plc - SWOT Analysis
SWOT Analysis - Overview
LivaNova Plc - Strengths
LivaNova Plc - Weaknesses
LivaNova Plc - Opportunities
LivaNova Plc - Threats
LivaNova Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
LivaNova Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
LivaNova Plc, Medical Equipment, Deals By Type, 2018 to YTD 2024
LivaNova Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 23, 2024: LivaNova to Present at the Goldman Sachs Healthcare Conference
May 01, 2024: LivaNova Reports First-Quarter 2024 Results
Apr 30, 2024: LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
Apr 30, 2024: LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
Apr 25, 2024: LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
Feb 05, 2024: LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director
Oct 06, 2023: LivaNova Board Appoints J. Christopher Barry as New Director
Sep 21, 2023: LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023
Aug 07, 2023: Liva Appoints New CMO and CCO & UK GM
May 03, 2023: LivaNova Reports First-Quarter 2023 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
LivaNova Plc, Key Facts
LivaNova Plc, Key Employees
LivaNova Plc, Key Employee Biographies
LivaNova Plc, Major Products and Services
LivaNova Plc, History
LivaNova Plc, Subsidiaries
LivaNova Plc, Key Competitors
LivaNova Plc, Ratios based on current share price
LivaNova Plc, Annual Ratios
LivaNova Plc, Annual Ratios (Cont...1)
LivaNova Plc, Annual Ratios (Cont...2)
LivaNova Plc, Interim Ratios
LivaNova Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
LivaNova Plc, Medical Equipment, Deals By Type, 2018 to YTD 2024
LivaNova Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
LivaNova Plc, Performance Chart (2019 - 2023)
LivaNova Plc, Ratio Charts
LivaNova Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
LivaNova Plc, Medical Equipment, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings